This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Galapagos Nv. Active years: 2016-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2019
Title: Gerben Albert Eleutherius Van 't Klooster: Innovator in Cardiovascular and Inflammatory Treatments
Introduction
Gerben Albert Eleutherius Van 't Klooster is a notable inventor based in Mechelen, Belgium. He has made significant contributions to the field of medicine, particularly in the treatment of cardiovascular disorders and inflammatory conditions. With a total of 2 patents to his name, his work is recognized for its innovative approaches to complex health issues.
Latest Patents
Van 't Klooster's latest patents include groundbreaking methods for the treatment of cardiovascular disorders. The first patent discloses compounds according to Formula (I) or a pharmaceutically acceptable salt thereof, aimed at the prophylaxis and treatment of cardiovascular disorders and dyslipidemia. The second patent focuses on aminotriazolopyridine for use in treating inflammation and related diseases. This invention highlights the compound's ability to inhibit JAK, a family of tyrosine kinases, and provides pharmaceutical compositions for various inflammatory conditions.
Career Highlights
Currently, Van 't Klooster is associated with Galapagos NV, a company known for its innovative research in biotechnology. His work at Galapagos has positioned him as a key player in the development of new therapeutic solutions. His contributions have been instrumental in advancing the understanding and treatment of complex medical conditions.
Collaborations
Throughout his career, Van 't Klooster has collaborated with esteemed colleagues such as Piet Tom Bert Paul Wigerinck and Réginald Christophe Xavier Brys. These collaborations have fostered a rich environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Gerben Albert Eleutherius Van 't Klooster is a distinguished inventor whose work in cardiovascular and inflammatory treatments has made a lasting impact on medical science. His innovative patents and collaborations continue to pave the way for future advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile